Clinical Trial

TCM Conservative Treatment for the Degenerative Lumbar Spinal Stenosis

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Lumbar degenerative disease is a common disease develops into degenerative lumbar spinal stenosis(DLSS)in the elderly and eventually. The long course of disease and other characteristics determine that conservative treatment cannot be effective in a short time, surgery is recommended to relieve symptoms quickly. However, the incidence of complications and disease recurrence rate after surgical treatment is high, and the reoperation rate is as high as 30-50%. Conservative treatment has the advantages of low price and high acceptance, so the treatment strategy first returns to conservative treatment.The complexity and repeatability of DLSS are the main reasons for the adoption of comprehensive treatment in modern medicine, but the efficacy is not significant. Traditional Chinese medicine (TCM) has its own theories and various methods to treat low back pain.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-03-09; most recent amendment 2024-08-06.
Status change: Recruiting → Active, Not Recruiting 2024-08-06
Status change: Not Yet Recruiting → Recruiting 2023-02-06
Trial Details
NCT Number NCT05273346
Lead Sponsor Beijing University of Chinese Medicine
Conditions Degenerative Lumbar Spinal Stenosis
Enrollment 94 participants
Start Date 2022-09-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-09